On behalf of the Molecular Diagnostics Europe team from the Cambridge Healthtech Institute, P-BIO is pleased to inform that the Final Agenda for the Seventh International Molecular Diagnostics Europe conference is now available. In addition, early registration discounts of up to €350 are available until 8 February.
This meeting provides a nexus for diagnostic developers in academia and industry as well as end users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in the prenatal, oncology, infectious disease, point-of-care, and liquid biopsy fields, plus new coverage of biomarkers for immunotherapy and companion diagnostics for immuno-oncology.
Taking place from 6-9 May 2019 in beautiful Lisbon, Portugal, the 2019 event will feature six Conferences plus a special one-day Symposium:
» Advances in Prenatal Molecular Diagnostics – Special One-Day Symposium!
» Biomarkers for Immunotherapy – New Topic!
» Companion Diagnostics for Immuno-Oncology – New Topic!
» Advanced Diagnostics for Infectious Disease
» Point-of-Care Diagnostics
» Enabling Technologies for Circulating Biomarkers
» Clinical Applications of Circulating Biomarkers
We are excited to announce the details for this year’s Plenary Session:
Precision Diagnostics in Oncology: Expanding Roles of Liquid Biopsies
Nitzan Rosenfeld, PhD, Senior Group Leader, Cancer Research UK Cambridge Institute, University of Cambridge; CSO, Inivata Ltd., United Kingdom
Legal and Regulatory Developments in Precision Medicine and Diagnostic Devices
Erik Vollebregt, Partner, Axon Lawyers, The Netherlands
PANEL DISCUSSION: Challenges and Opportunities in European Diagnostic Investments
Moderator: Diana Saraceni, Founder, Managing Partner, Panakes Partners, Italy